Halifax, NS – December 10, 2025 – Allumiqs is pleased to announce the appointment of Derek Gooderham as President of the Company to lead all core operational and commercial functions, marking an exciting new chapter in its evolution as a customer success–driven organization.
With more than 30 years of experience, Derek brings a proven track record of leadership and strategic vision that will strengthen Allumiqs’ commitment to delivering exceptional value to customers across the biotech and life sciences landscape. His appointment highlights the Company’s dedication to building lasting partnerships and ensuring that customer success remains at the heart of every initiative.
“Allumiqs has always been defined by its ability to help customers unlock insights and achieve meaningful outcomes,” said Derek Gooderham. “I look forward to expanding my role to work with our talented team to accelerate data-driven growth strategies, achieve high performance operational scalability, and expand our impact with customer-focused solutions delivery.”
As President, Derek will focus on guiding Allumiqs through its next phase of growth, ensuring that the Company continues to innovate while staying true to its mission of empowering customers with innovative solutions to accelerate discovery. His leadership sets the stage for scaling operations, strengthening industry partnerships, and driving commercial success. Kent MacLean, CEO, Allumiqs, added “Derek’s appointment as President reflects our commitment to delivering exceptional value to our customers while positioning the Company for sustainable growth. His strategic execution, together with strong commercial and operational leadership, set the stage for an exciting new chapter at Allumiqs.”
About Allumiqs
Allumiqs is a multiomics Contract Research Organization (CRO) specializing in proteomics, metabolomics, lipidomics, and small molecule analysis powered by advanced mass spectrometry. Delivering precise, high-impact data, Allumiqs helps biotech and biopharma organizations de-risk drug development and accelerate innovations from discovery to patient value. Collaborating with Allumiqs brings customers access to its dedicated team of scientists and world-class channel partners. allumiqs.com
Media Contact:
Allumiqs – Andrea Young, [email protected]